GlobeNewswire Inc.·Apr 28·Pomerantz LlpBayCom Faces Legal Scrutiny After Executive Exodus and Stock PlungeLaw firm investigates BayCom Corp following sudden departure of CEO, COO, CFO. Stock fell 11.11% on strategic shift away from acquisitions. BCMLsecurities fraudstock decline
GlobeNewswire Inc.·Apr 28·Pomerantz LlpCarMax Stock Plunges 15% as Law Firm Probes Earnings Guidance Amid Affordability PushPomerantz LLP investigates CarMax for potential securities fraud after stock fell 15% following April earnings announcement and pricing strategy shift. KMXsecurities fraudclass action
GlobeNewswire Inc.·Apr 28·Rosen Law FirmGossamer Bio Hit by Securities Class Action Over Misleading Phase 3 Trial DataRosen Law Firm sues Gossamer Bio ($GOSS) over alleged misstatements about Phase 3 trial design. Lead plaintiff deadline: June 1, 2026. GOSSsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Hagens BermanGemini Space Station Stock Plunges 75% as Founders Face Investor Lawsuit Over Misleading ClaimsSecurities lawsuit filed against $GEMI and founders Cameron and Tyler Winklevoss alleging investor deception. Stock crashed from $28 IPO to below $7 following strategic pivot. GEMIsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpByrna Technologies Plummets 31% on Weak Online Sales; Law Firm Probes Fraud ClaimsPomerantz LLP investigates Byrna Technologies for potential securities fraud after April earnings revealed deteriorating online sales, conversion rates, and order values, triggering steep stock decline. BYRNsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpVeritone Faces Securities Probe After $2.48M Revenue RestatementPomerantz Law Firm investigates Veritone after accounting errors reduced Q3 2025 revenue by $2.48M. Stock plunged 8.33% to $2.09 on disclosure. VERIKMXBCMLsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpADMA Biologics Faces Securities Fraud Investigation Amid Channel Stuffing AllegationsPomerantz Law Firm investigates $ADMA for potential securities fraud after Culper Research alleges channel stuffing, with stock plunging 30% in two days. ADMAsecurities fraudstock decline
GlobeNewswire Inc.·Apr 28·Hagens BermanTrip.com Faces Class Action Over AI Tool Disclosure; Investors Rally Behind CaseSecurities lawsuit targets $TCOM over alleged misleading disclosures about AI pricing tool regulatory risks. Stock plunged 17% after Chinese antitrust investigation disclosure. TCOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpBadger Meter Stock Plunges 24% After Earnings Miss, Securities Fraud Probe LaunchedPomerantz LLP investigates $BMI following massive earnings miss and 24% stock collapse. Revenue fell short by $28.58M; utility water sales declined 10% YoY. BMIsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Hagens BermanApollo Global Faces Major Securities Lawsuit Over Epstein Relationship ConcealmentApollo Global Management faces securities lawsuit alleging false statements about Jeffrey Epstein relationship. Stock fell 15%, erasing $12 billion in market value. Lead Plaintiff deadline: May 1, 2026. APOAPOSAPOpAsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpAlstom Stock Plummets on Missed Targets; Law Firm Launches Investor InvestigationPomerantz LLP investigates Alstom for potential securities fraud following April 16 disclosure of missed guidance, margin misses, and €1.5B cash flow guidance withdrawal. ALSMYsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Hagens BermanODDITY Tech Stock Collapses 49% Amid AI Model Disruption, Class Action FiledHagens Berman sues $ODD over 49% stock collapse after AI partner algorithm changes disrupted primary ad account, causing projected 30% Q1 revenue decline. ODDsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpHTGC Faces Class Action Over Alleged Fraud; Stock Tumbles 7.91% Following Short ReportPomerantz Law Firm files class action lawsuit against Hercules Capital ($HTGC) alleging securities fraud following damaging short report. Investors can claim lead plaintiff status until May 19, 2026. HCXYHTGCsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpJourney Medical Stock Crashes 30% After Reimbursement Disclosure Sparks Fraud InvestigationPomerantz LLP investigates $DERM for potential securities fraud after revealing prescription-revenue disconnect tied to reimbursement timing issues. DERMsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpBitGo Stock Crashes 68% Post-IPO as $14.8M Loss Triggers Fraud InvestigationPomerantz Law Firm investigates potential securities fraud at $BTGO following 68% stock plunge after company reported $14.8M loss versus $156.6M profit prior year. BTGOsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpUpstart Hit With Securities Fraud Class Action Over AI Model MisrepresentationsPomerantz Law Firm files class action against $UPST and officers, alleging false statements about AI lending model accuracy. Stock fell 9.71% after November disclosure. UPSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpChowChow Cloud Plummets 84% Amid Fraud Investigation and Trading HaltsChowChow Cloud stock crashed 84.3% after pump-and-dump scheme investigation reveals fake financial advisors inflated price via social media. CHOWsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpPinterest Faces Class Action Lawsuit Over Misleading Statements on Economic HeadwindsPomerantz LLP filed class action lawsuit against Pinterest for allegedly misleading investors about macroeconomic and tariff challenges. Stock declined following reduced guidance and missed earnings. PINSsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpCamping World Stock Plummets 41% as Class Action Lawsuit Targets Securities FraudCamping World stock plummets 41% following Q3-Q4 losses; class action lawsuit alleges securities fraud. Investors have until May 11, 2026 to seek Lead Plaintiff status. CWHsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Apr 28·Pomerantz LlpAtara Biotherapeutics Hit With Securities Fraud Class Action Over Failed Drug ApprovalPomerantz Law Firm files class action against $ATRA over alleged misstatements regarding tabelecleucel's regulatory prospects, following FDA rejections and severe stock declines. ATRAsecurities fraudclass action lawsuit